Table 2.
Referral acceptance and treatment adherence of infants 0–59 days of age with signs of PSBI (n = 1860)
| PSBI classification | ||||
|---|---|---|---|---|
| Parameters | Fast breathing 7–59 days n (%) | Fast breathing 0–6 days n (%) | Clinical severe infection n (%) | Critical illness n (%) § |
| Number of young infants identified with PSBI at BHUs | 923 | 344 | 495 | 98 |
| Number brought by families to the BHU (self-referral) | 567 (61.4) | 200 (58.1) | 302 (61.0) | 44 (44.9) |
| The number identified by the LHW in the community and referred to the BHU | 356 (38.6) | 144 (41.9) | 193 (39.0) | 54 (55.1) |
| Number of infants accepted referral to a hospital | 0 (0.0) | 9 (2.6) | 55 (11.1) | 92 (93.9) |
| Number of infants treated at a BHU with a simplified antibiotic regimen on an out-patient basis | 923 (100.0) | 335 (97.4) | 440 (88.9) | 6 (6.1) |
| Adherence to treatment in young infants treated with a simplified antibiotic regime at BHU | ||||
| Fully adherent* | 708/923 (76.7) | 238/335 (71.0) | 305/440 (69.3) | 1/6(16.7) |
| Partially adherent† | 71/923 (7.7) | 28/335 (8.4) | 63/440 (14.3) | 1/6(16.7) |
| Non adherent‡ | 144/923 (15.6) | 69/335 (20.6) | 72/440 (16.4) | 4/6 (66.7) |
| Follow-up of infants who accepted treatment at BHU | ||||
| Number completed all follow-up visits§ | 596/923 (64.6) | 206/335 (61.5) | 170/440 (38.6) | 1/6(16.7) |
| Number successfully followed-up on day 4 | 758/923 (82.1) | 272/335(81.2) | 349/440 (79.3) | 5/6 (83.3) |
*Fully adherent: for critical illness seven gentamicin+14 ampicillin injections, for clinical severe infection two injections of gentamicin +14 oral amoxicillin doses, for fast breathing 14 oral amoxicillin doses
†Partially adherent: critical illness five gentamicin+10 ampicillin, for clinical severe infection one injections of gentamicin +10–13 oral amoxicillin doses, for fast breathing 10–13 oral amoxicillin doses
‡Non-adherent: not fulfilling the definition of full or partial adherence.
§For critical illness the complete follow-up is on days1–8 and 14, for the clinical severe infection the complete follow-up is on days 2, 4, 8 and 14 and for fast breathing, the complete follow-up is on day 4, 8 and 14.